文献速递骨软组织肉瘤与黑色素瘤

黑色素瘤无创诊断进展:超越ABCD法则40年

Advances in the noninvasive diagnosis of melanoma-40 years beyond the ABCDs.
PubMed 文献 · CA Cancer J Clin · 2026-01-01

皮肤黑色素瘤早期检测对生存至关重要,但美国不到一半的黑色素瘤由皮肤科医生诊断。ABCDE法则作为全球裸眼非设备辅助的初始分诊标准已使用40年。本临床综述讨论当前一线和二线黑色素瘤检测模式,更新一线分诊方法,并探讨监管机构对皮肤癌检测技术安全有效使用的监管挑战。

要点

  • ABCDE法则仍是全球裸眼非设备辅助的黑色素瘤初始分诊标准。
  • 美国不到一半的黑色素瘤由皮肤科医生诊断,凸显非专科医生培训重要性。
  • 临床需了解当前一线和二线黑色素瘤检测技术以提升诊断能力。

核心结论

  • 医疗专业人员需了解当前皮肤癌检测技术以增强黑色素瘤诊断能力。

主要发现

  • 美国不到一半的黑色素瘤由皮肤科医生诊断。
  • ABCDE法则已作为全球裸眼非设备辅助的初始分诊标准使用40年。

临床怎么用

  • 非皮肤科医生和公众可使用ABCDE法则进行色素性病变的初始分诊。
  • 临床医生应了解当前一线和二线黑色素瘤检测模式以辅助诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The early detection of cutaneous melanoma is critical to survival outcomes. Because less than one half of melanomas in the United States are diagnosed by dermatologists, the ABCD (asymmetry, border irregularity, color variation, diameter >6 mm) acronym, created 40 years ago with the later addition of "E" for evolution (ABCDE), was developed for nondermatologist health care professionals and the public to simplify and enhance the diagnosis of early melanoma. It continues to be the global, naked-eye, nondevice-assisted standard for initial triage of pigmented lesions. This clinical review discusses the changing clinical diagnostic landscape and examines the currently available first-line and second-line detection modalities for melanoma. It also provides updates to the first-line triage approach and discusses the challenges of regulatory agency oversight for the safe and effective use of current and emerging skin cancer detection technologies. It is critical that health care professionals globally have knowledge of these technologies to enhance their diagnosis of melanoma.

来源:CA Cancer J Clin,查看原文。版权归原作者所有。

引用

  1. Burshtein J, Witkowski A, Zakria D, et al. Advances in the noninvasive diagnosis of melanoma-40 years beyond the ABCDs. CA Cancer J Clin. 2026. PMID: 41614452. doi:10.3322/caac.70065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。